Mechanisms of murine dendritic cell antitumor dysfunction in aging
/in International Publications, Malignant Melanoma, NSCLC /von 2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-9Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer – a phase II study
/in Hyperthermia, International Publications, Ovarian Cancer /von 2008-12-06 / Gynecol. Oncol. 2009 Feb;112(2):384-8Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer
/in International Publications, NSCLC /von 2008-12-04 / Lung Cancer 2009 Jul;65(1):1-8Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol
/in Hyperthermia, International Publications /von 2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-62
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution